![Kevin R. McIntosh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin R. McIntosh
Keine laufenden Positionen mehr
Karriereverlauf von Kevin R. McIntosh
Ehemalige bekannte Positionen von Kevin R. McIntosh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Cognate BioServices, Inc.
![]() Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 | - |
Ausbildung von Kevin R. McIntosh
University of Illinois | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cognate BioServices, Inc.
![]() Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Health Technology |
Osiris Therapeutics, Inc.
![]() Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
- Börse
- Insiders
- Kevin R. McIntosh
- Erfahrung